Definitive Contract HHSN268201000019C
- Not listed
- This is a definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to The Regents of the University of California, San Francisco (UCSF) on March 29, 2010. The contract, valued at $1,930,904.73, is for a recovery act project to provide radiologic outcomes for the Osteoarthritis Initiative (OAI), which is sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The contract is a firm fixed price arrangement and...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) on February 2, 2009. The $3,319,012.92 Definitive Contract is for biomedical research and has a period of performance through July 31, 2016. The contract does not have a set-aside designation. As a leading academic medical center and research institution, UCSF has a strong...
- This federal contract award, with an ID of HHSN268201200031C, was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to The Regents of the University of California, San Francisco (UCSF) for the Osteoarthritis Initiative Data Coordinating Center. The definitive, cost-no-fee contract has a ceiling value of $8,811,628.18 and a completion date of October 31, 2017. It does not have a set-aside designation. Under this contract, UCSF will coordinate the Osteoarthritis...
- The Department of Health and Human Services National Institutes of Health awarded a definitive, cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for $6,657,300.68. The contract is for biomedical (basic) services and does not have a set-aside designation. UCSF, a public academic medical center and research university, is providing services through its Controller's Office division. The contract commenced on September 30, 2004 and is scheduled for completion...
- The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health, awarded a definitive contract to the Regents of the University of California for applied and exploratory biomedical research. The contract, valued at $1.13M on a cost, no-fee basis, was awarded on April 15, 2003, with an ultimate completion date of September 29, 2011. The work is being performed in San Francisco, California, and no small business set-aside was utilized for this...
- This federal contract award is for biomedical research and services, with a total ceiling value of $10,607,389.80. The contract was awarded on March 28, 1996 to the prime contractor, The Regents of the University of California, San Francisco (UCSF), and has an ultimate completion date of February 14, 2013. The contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract is a definitive...
- This is a $1,809,248.54 cost-type definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) for the "Prevention of Anastomotic Intimal Hyperplasia by a Pro-Resolving Perivascular Device" research project. The contract supports the development and testing of a medical device designed to prevent a cardiovascular condition called...
- This $639,119.55 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to The Regents of the University of California, San Francisco (UCSF), a state-controlled institution of higher learning, for the DBDR REDS-III Domestic Site Phase 3 project. The contract is a delivery order under the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites major program, with a period of...
- This is a firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Regents of the University of California, San Francisco (UCSF) for a Pustular Psoriasis Study clinical trial site. The $59,999.67 contract has a period of performance from September 20, 2018 to September 19, 2020. The contract was not set aside for any specific category. UCSF is a prominent academic medical center and research...
- This is a $1,185,983.00 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF). The contract is for the SUBPOPULATIONS AND INTERMEDIATE OUTCOMES IN COPD (SPIROMICS) III - SPIROMICS - TASK AREA B project, which is a continuation of a larger SPIROMICS research program. The contract does not have a set-aside designation and is scheduled for...
This is a definitive cost-no-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) on June 15, 2010. The contract, valued at $2,025,201.08, supports research on hip morphology and limb-specific risk factors for radiographic hip osteoarthritis. UCSF, a leading academic medical center and research institution, is the prime contractor for this effort. The contract was awarded without any set-aside designation. As a major recipient of NIH funding, UCSF collaborates with federal agencies, academic institutions, and industry partners on a wide range of biomedical research initiatives aimed at improving human health.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 5 | Other Administrative Action | ($8k) | 9/21/15 | |
| 4 | Change Order | $0 | 6/15/15 | |
| 3 | Other Administrative Action | $0 | 12/10/13 | |
| 2 | Other Administrative Action | $0 | 7/9/12 | |
| 1 | Funding Only Action | $1.6m | 9/10/10 |